We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Pacientes em uso crônico de prednisona: perfil Clínico e laboratorial.
- Authors
COSTA, Ana Carolina Assis; BOLINA, Virgínia Maria Gonçalves; RODRIGUES, João Paulo Vilela; REIS, Tiago Marques; OLIVEIRA, Cláudia Di Lorenzo; BALDONI, André Oliveira
- Abstract
Objective: To identify patients frequency and profile in prednisone chronic use without preventive treatment for osteoporosis corticoid- induced and to describe the laboratory abnormalities potentially associated with prednisone use. Methods: A descriptive study was carried out with a structured questionnaire, as well as the analysis of metabolic changes. Data collection was carried out from August 2015 to July 2016. Results: The dose of 5mg/day of prednisone was the most prevalent (64.7%), the majority used the drug for five to eight years (32.4%), and 88.2% did not use preventive treatment for osteoporosis. Among the interviewees, 21 performed laboratory tests, and 57.1% presented low density lipoprotein (LDL) levels above the recommended, 33.3% presented fasting blood glycemia level higher than 99mg/dL, 28.6% presented levels of very low density lipoprotein (VLDL) and triglycerides above of reference values. Discussion: Chronic use of corticosteroids may be one of the factors associated with patients metabolic changes. Conclusion: The frequency of patients who use prednisone and do not undergo preventive treatment for osteoporosis is high (88.2%), as well as changing in laboratory tests.
- Publication
Electronic Journal of Pharmacy / Revista Eletrônica de Farmácia, 2018, Vol 15, p1
- ISSN
1808-0804
- Publication type
Article
- DOI
10.5216/ref.v15ie.47974